The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

What can we do to ensure that those we rely upon to care for us, are being supported in this essential, important work?

First approval in 16 years for mesothelioma, a type of cancer caused by inhaling asbestos fibers SILVER SPRING, Md., Oct. 2, 2020 /PRNewswire/ -- Today, the U.S. Food...